The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

  title={The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.},
  author={Jussi K. Huttunen and Olli Heinonen and Vesa Manninen and Pekka Koskinen and Timo Hakulinen and Lyly H I Teppo and Matti M{\"a}ntt{\"a}ri and Maria Frick},
  journal={Journal of internal medicine},
  volume={235 1},
OBJECTIVES Earlier monitoring of all symptoms, hospital admissions, cancer diagnoses and causes of death during gemfibrozil treatment had raised some suspicions which called for further follow-up. DESIGN Close monitoring of selected, potentially adverse events amongst treated subjects after a placebo-controlled trial and comparing occurrences to those in various untreated groups. SETTING All participants of the Helsinki Heart Study (a controlled, 5-year, multi-clinic coronary heart disease… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 32 extracted citations

Similar Papers

Loading similar papers…